Downstream Processing Market Size, Share & Trends Analysis growing at a CAGR of 14.49% from 2025 to 2030
The global downstream processing market size valued at USD 41.81 billion in 2024 and projected to reach USD 94.79 billion by 2030, growing at a CAGR of 14.49% from 2025 to 2030. The downstream processing industry’s growth is primarily driven by the growing demand for biologics, including monoclonal antibodies, vaccines, and recombinant proteins, which require efficient purification and separation techniques.
Market Size & Trends:
- North America dominated the downstream processing industry with the largest revenue share of 40.4% in 2024.
- The U.S. is the largest downstream processing industry for downstream processing.
- Based on products, the chromatography systems segment dominated the market for downstream processing and accounted for the largest revenue share of 41.43% in 2024.
- By technique, the purification by chromatography segment dominated the downstream processing market and accounted for the largest revenue share of 41.79% in 2024.
- Based on application, the antibiotic production segment dominated the market for downstream processing. It generated the largest revenue share of 29.84% in 2024.
Key Market Statistics:
- 2024 Market Size: $41.81 billion
- 2030 Estimated Market Size: $94.79 billion
- CAGR: 14.49% (2025-2030)
- North America: Largest market in 2024
- Asia Pacific: Fastest growing region
Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/downstream-processing-market/request/rs1
Advancements in single-use technologies and automation are streamlining workflows, reducing contamination risks, and improving scalability. Additionally, increased R&D investments in biopharmaceuticals, the rise of biosimilars, and expanding vaccine manufacturing capabilities globally are further fueling market growth. Regulatory support for high-purity biologics and the surge in cell and gene therapies are also contributing to the market’s upward trajectory.
Emerging technologies for the integration & intensification of downstream bioprocesses
The downstream processing market is witnessing a growing shift from traditional, segmented workflows toward integrated downstream processing (iDSP) solutions. While traditional DSP involves separate, often manual steps for cell separation, purification, and polishing, integrated DSP consolidates these processes into more streamlined, automated systems. This integration improves process efficiency, reduces footprint, lowers operational costs, and minimizes product loss, all critical in the context of rising biologics demand. The increasing focus on continuous manufacturing, coupled with the need to accelerate time-to-market for complex biologics such as monoclonal antibodies, cell and gene therapies, and biosimilars, is fueling the adoption of integrated DSP systems.
